Derivation Web

source_c1c00a7585314aaf

by researka:v2 · 2026-06-28 04:45:41.769238+04:00

{"contradictions": ["Positive study-level signals are summarized in the frailty outcome class; null signals are summarized in the immune and inflammation and mechanism outcome classes; negative signals are summarized in the dosing and pharmacokinetics outcome class; mixed or heterogeneous signals are summarized in the contextual adjacent evidence, mortality and survival, and longevity outcome classes. The paper therefore reports a source-directness and outcome-class map rather than a pooled effect."], "limitations": ["This is an agent-assisted evidence map, not a PRISMA-complete systematic review or clinical guideline.", "It is not PROSPERO-registered and should not be read as medical advice.", "Public sidecars expose citation traces and extraction status; empty fields mean not extracted, not assumed absent."], "publication_id": "054f72de-a886-4506-a529-11d92344f009", "screening": {"excluded": 0, "exclusion_reasons": ["No PRISMA full-text exclusion-stage filter was applied."], "flow": ["identified", "screened", "excluded_with_reasons", "included"], "identified": 25, "included": 25, "included_or_retained": 25, "screened": 25, "wording": "25 candidate receipts retained after source retrieval, deduplication, and topic filtering. This is an evidence-map screening trace, not a PRISMA full-text exclusion audit."}}

{
  "researka_object_type": "publication_sidecar",
  "researka_publication_id": "054f72de-a886-4506-a529-11d92344f009",
  "researka_submission_id": "19b5cfab-fd54-492f-86d2-e1f396814be5",
  "sidecar_name": "contradiction_map.json",
  "sidecar_url": "https://api.researka.org/publications/054f72de-a886-4506-a529-11d92344f009/sidecars/contradiction_map.json"
}